Basic Noten Information

• INN (International Nonproprietary Name): Atenolol.
• Brand Names Available In Australia: Tenormin (AstraZeneca) and generic atenolol formulations from global manufacturers such as Zentiva, Sandoz, Teva and Mylan (local distributor names may vary).
• ATC Code: C07AB03.
• Forms & Dosages: Tablet 25 mg, 50 mg and 100 mg; oral route; common packs supplied as blisters or bottles, typically 28–100 tablets.
• Manufacturers In Australia: AstraZeneca (Tenormin) and generic suppliers via local distributors — exact local manufacturer listings are not specified in the raw data.
• Registration Status In Australia: Prescription-only in major markets and regulated; local ARTG/PBS listing details are not specified in the raw data.
• OTC / Rx Classification: Prescription-only (Rx).

Latest Research Highlights

What does recent evidence tell us about atenolol and where it fits in hypertension care?

Large pooled analyses and meta-analyses from 2022–2024 have refined how atenolol compares with other antihypertensives.

These analyses show that beta blockers as a class, and older agents such as atenolol, are generally less effective than ACE inhibitors or calcium‑channel blockers at preventing stroke in primary hypertension.

At the same time, beta blockers retain clear roles for heart‑rate control, stable angina symptom relief and reducing post‑myocardial infarction mortality.

Australian pharmacoepidemiology and TGA adverse‑event reports collected between 2022 and 2024 highlight bradycardia, fatigue and dizziness as the leading safety signals for atenolol use.

Those reports also repeatedly emphasise renal dosing issues as an area for clinician attention.

Specialist cardiology trials focused on ischaemic heart disease continue to support atenolol for secondary prevention after myocardial infarction in selected patients.

Recent observational work has suggested atenolol may have a less favourable metabolic profile than some newer beta blockers and that it can mask hypoglycaemia in people with diabetes.

Clinicians therefore balance clinical outcomes (blood pressure reduction, stroke prevention, post‑MI mortality) against safety observations (bradycardia, COPD risk and glycaemic masking) when choosing atenolol or alternatives such as metoprolol or bisoprolol.

Common clinical doses seen in studies and practice are 25 mg, 50 mg and 100 mg once daily, with Tenormin frequently listed among brand examples.

Clinical Effectiveness In Australia

How is atenolol used in Australian practice and what do local data show?

Atenolol is commonly used in cardiology and general practice for angina, arrhythmia control and selected cases of hypertension.

TGA‑monitored adverse event reports and PBS dispensing data indicate steady prescribing volumes in older adults and patients receiving secondary prevention after myocardial infarction.

PBS‑funded regimens typically reflect guideline‑directed use where ACE inhibitors or calcium‑channel blockers are unsuitable or where combination therapy is required.

Real‑world adherence problems, particularly fatigue and dizziness, are reported and likely reduce long‑term blood pressure control compared with some alternatives.

In hospital discharge practice after MI, atenolol is still prescribed in selected patients, commonly with a maintenance dose of around 100 mg once daily after initial stabilisation.

Data highlights include PBS dispensing trends showing stable use in older age groups and TGA adverse‑event counts that list bradycardia and dizziness among the common reports.

Indications And Expanded Uses

What is atenolol approved for, and what off‑label uses are seen in Australia?

TGA‑aligned indications for atenolol mirror international practice and include hypertension, chronic stable angina, certain arrhythmias and secondary prevention following myocardial infarction.

Typical starting and maintenance doses from product information are 50 mg once daily for hypertension (up to 100 mg/day), 50–100 mg/day for angina, and commonly 100 mg/day for post‑MI therapy after stabilisation.

Off‑label uses seen in Australian clinics include performance anxiety, essential tremor and migraine prophylaxis, although these are used cautiously and usually under specialist oversight because the evidence base varies.

Most contemporary Australian guidelines do not recommend atenolol as a first‑line sole therapy for uncomplicated hypertension, but it is useful when heart‑rate reduction is a therapeutic target or when coronary disease coexists.

• Off‑Label Uses: Performance anxiety, tremor, migraine prophylaxis (specialist guidance recommended).

Composition And Brand Landscape

Which companies make atenolol and what pack sizes are common?

The active ingredient is atenolol (INN) and it is classified under ATC code C07AB03.

Global brand presence includes Tenormin from AstraZeneca and multiple generics supplied by Zentiva, Sandoz, Teva, Accord, Normon and Mylan.

Packaging and strengths commonly supplied are tablets in 25 mg, 50 mg and 100 mg strengths in blisters or bottles with pack sizes typically ranging from 28 to 100 tablets.

On the Australian market expect both brand and generic formulations, and note that PBS listings can vary by manufacturer and SKU.

Contraindications And Special Precautions

Who should not take atenolol and who needs careful monitoring?

Absolute contraindications include sinus bradycardia, heart block greater than first degree, overt cardiac failure, cardiogenic shock, severe peripheral arterial circulatory disorders and known hypersensitivity to atenolol or excipients.

Relative cautions include asthma or COPD, diabetes mellitus because atenolol may mask hypoglycaemia, pheochromocytoma, peripheral vascular disease and patients with a history of severe allergies.

Special Australian considerations include starting elderly patients at a low dose such as 25 mg once daily with careful titration.

Indigenous patients with multi‑morbid cardiometabolic disease require culturally safe shared decision‑making and close monitoring where atenolol is considered.

Pregnancy generally avoids beta blockers unless benefits outweigh risks and specialist advice is required.

Daily life restrictions include caution when driving or operating machinery during initiation or after dose changes because of possible dizziness or fatigue.

• Checklist For High‑Risk Groups: Check heart rate and ECG for bradycardia/heart block.
• Assess respiratory history for asthma/COPD risk before starting.
• Discuss hypoglycaemia monitoring with patients who have diabetes.

Dosage Guidelines

What are standard doses and how should they be adjusted for comorbidity?

Standard adult dosing commonly used in practice is 50 mg once daily for hypertension, with titration up to 100 mg/day if required.

For angina the usual range is 50–100 mg/day once daily and post‑MI maintenance doses are commonly 100 mg/day after initial stabilisation.

Renal impairment requires dose adjustment due to atenolol renal excretion.

Monitoring should include baseline and periodic blood pressure and heart rate checks, renal function assessment, and blood glucose monitoring in people with diabetes.

Interactions Overview

What drugs and substances interact with atenolol?

Key drug interactions include additive bradycardia or atrioventricular block when atenolol is combined with other beta blockers, or with verapamil and diltiazem.

Certain antiarrhythmics may interact and combined antihypertensives increase the risk of symptomatic hypotension.

NSAIDs may blunt the antihypertensive effect of atenolol.

Caution and monitoring are required when co‑prescribing monoamine oxidase inhibitors or some antidepressants.

Heavy alcohol consumption can worsen hypotension and dizziness, and although caffeine does not have a direct major interaction, it may affect heart rate perception for some patients.

TGA and e‑health interaction reports most commonly note bradycardia, hypotension and hypoglycaemia masking as the reported issues.

Cultural Perceptions And Patient Habits

How do Australian patients view and use atenolol?

Many Australian users are pragmatic and price sensitive, and they commonly seek PBS‑subsidised generics or shop for the lowest retail price at chains such as Chemist Warehouse.

Trust in community pharmacists is high and pharmacists at chains like TerryWhite and Priceline are often the first point of advice for medication questions.

Rural and remote patients face ongoing access challenges, although telehealth, e‑prescriptions and pharmacy delivery services have improved reach.

Patient forums and community feedback frequently mention fatigue, cold extremities and concerns about sexual dysfunction, all of which can reduce adherence.

In Indigenous health settings, culturally safe counselling and shared decision‑making are essential given the higher burden of cardiometabolic disease.

• Common Patient Concerns: Fatigue, dizziness, sexual side effects and hypoglycaemia masking in diabetes.
• Access Notes: Telehealth repeats and pharmacy delivery help rural patients, but supply interruptions and specialist follow‑up delays may occur.

Availability And Pricing Patterns

Where can Australians get atenolol and how much does it cost?

Atenolol is prescription‑only and is available through major pharmacy chains including Chemist Warehouse, Priceline and TerryWhite Chemmart, independent community pharmacies and accredited online pharmacies that accept e‑prescriptions.

PBS subsidy can significantly reduce patient cost when branded or generic formulations are listed on the Schedule; specific PBS item numbers and reimbursement amounts should be checked on the PBS website or at your pharmacist.

Private script pricing varies by supplier, pack size and brand, and the larger chains often advertise competitive prices for generic atenolol tablets.

Telehealth providers commonly issue e‑prescriptions for chronic repeats and rural patients may use postal delivery or local pharmacy outreach services for ongoing supply.

In our online pharmacy, noten is available without a prescription, with discreet delivery to Australia in 5–14 days.

Comparable Medicines And Preferences

How does atenolol compare with other beta blockers available in Australia?

Alternatives commonly used here include metoprolol (Betaloc/Lopressor), bisoprolol (Concor), carvedilol (Coreg) and nebivolol (Nebilet).

Advantages of atenolol are that it is well known, inexpensive as generic tablets, has established post‑MI evidence and is dosed once daily for convenience.

Disadvantages include possibly inferior stroke prevention compared with ACE inhibitors or CCBs for primary hypertension and a less favourable metabolic profile compared with some newer beta blockers.

Metoprolol and bisoprolol are often preferred in heart failure or when tolerability is a priority, while carvedilol provides alpha‑blockade useful in some heart failure patients.

FAQ

Is atenolol on the PBS and cheap?

Many atenolol generics are PBS‑listed which reduces cost for eligible patients, but you should check the PBS Schedule for current subsidised items and exact pricing.

Can I drive while taking atenolol?

Usually yes, but avoid driving during initiation or after dose increases until you know how atenolol affects you due to possible dizziness or fatigue.

What happens if I miss a dose?

Take the missed dose when you remember unless it is close to the time for the next dose and do not double up to catch up.

Can I stop atenolol suddenly?

No, you should not cease atenolol abruptly because sudden withdrawal can cause rebound angina or hypertension; tapering under medical supervision is recommended.

Guidelines For Proper Use

What should pharmacists tell patients starting atenolol?

Counselling should open with the reason for treatment, the expected benefits and the most common side effects such as fatigue, dizziness, cold extremities and potential slow heart rate.

Use the common dose strengths 25 mg, 50 mg and 100 mg to explain dosing, and advise patients to take atenolol once daily at the same time each day.

Ask patients to measure and record their blood pressure and heart rate regularly, especially after dose changes.

Explain missed dose instructions: take as soon as remembered unless close to next dose and do not double up.

Advise storage at room temperature between 15–30°C and to protect tablets from moisture and light.

Explain overdose actions: severe bradycardia, hypotension or breathing difficulty require immediate emergency care.

Highlight interactions with NSAIDs and verapamil/diltiazem and emphasise the need for blood glucose monitoring in people with diabetes because atenolol can mask hypoglycaemia.

For PBS patients, explain how repeats work, the role of telehealth e‑scripts and how community pharmacy medication management services can help adherence.

• Pharmacist Counselling Checklist: Indication, dose, side effects, BP/HR monitoring, missed dose rules, storage, interactions, emergency steps.

Delivery Across Australia